Investing Profile

Niall O’Donnell

InvestorVC
Managing Director at RiverVest Venture Partners
rivervest.com/team-member/nia...Encinitas, California
Photo of Niall O’Donnell, Managing Director at RiverVest
Your Intro Paths to Niall O’Donnell

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Niall O’Donnell on

cb
Current Investing Position
RiverVest Managing Director
Investment Range
$100K - $1M
Sweet Spot
$100K
Investments On Record
16
Current Fund Size
$184.4M

Niall O’Donnell is on these Sector & Stage Rankings

Niall O’Donnell's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
Atalanta Therapeutics
Series BJan 2025$97M
$210M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners), Jason P. Hafler (Sanofi Ventures)
Engrail Therapeutics
Series BMar 2024$160M
$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Peter Bisgaard (Pivotal bioVenture Partners), Heath Lukatch (Red Tree Venture Capital), Jasper Bos (Forbion)
Glycomine
Series BJun 2021$35M
$35M
Co-investors: Jim Trenkle (Sanofi Ventures), Bali Muralidhar (Abingworth)
Reneo Pharmaceuticals
Series BDec 2020$95M
Series AMay 2019$50M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Bali Muralidhar (Abingworth)
Amplyx Pharmaceuticals
Series CMay 2020$53M
Series CAug 2017$67M
Series BNov 2015$41M
$160M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Alex Kahn (Generation Ventures)
Mirum Pharmaceuticals
Series ANov 2018$120M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Patrick Heron (Frazier Healthcare Partners), Jonathan Leff (Deerfield Management)
Otonomy
Series DApr 2014$49M
Series CSep 2013$46M
Series BAug 2010$39M
Series BAug 2010$39M
$180M
Co-investors: Chau Khuong (OrbiMed), Peter Bisgaard (Pivotal bioVenture Partners), Brian Dovey (Domain Associates), John McKearn (RiverVest), Jay Lichter (Avalon Ventures), Bill Harrington (Osage University Partners), Heather Preston
Lumena Pharmaceuticals
Series BMar 2014$45M
Series AMay 2013$23M
$68M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), John McKearn (RiverVest)

Founders who looked at Niall O’Donnell's profile also looked at these Scouts & Angels

Photo of Michael Berman, Venture Partner at RiverVest

RiverVest